Skip to content

Association Between BMI and COVID-19

Relationship Between Obesity and Severe Acute Respiratory Syndrome Coronavirus-2 in Patient With SARS-CoV-2 Admitted in Intensive Care : A Multicenter Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04391738
Acronym
BMI-SARS-CoV-2
Enrollment
1200
Registered
2020-05-18
Start date
2020-02-01
Completion date
2020-09-01
Last updated
2021-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV 2

Keywords

Intensive Care, Invasive Mechanical Ventilation, Body Mass Index, Obesity

Brief summary

This study will involve collection of pseudonymized data from hospital-based data reporting at multiple international sites. Collating data from a large volume of patients with COVID-19 admitted in ICU across multiple international sites will enable investigation of whether obesity is a risk factor for complicated from of SARS-CoV-2 in adult patients and whether this association is independent of other cardiometabolic risk factors.

Detailed description

The COVID-19 pandemic is characterized by a high frequency of patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), who often require invasive mechanical ventilation (IMV). Body mass index (BMI) was however rarely mentioned in early clinical reports. Disease severity gradually increased with body mass index (BMI) categories among patients admitted in intensive care unit (ICU) for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the need for invasive mechanical ventilation (IMV), reaching 85% in patients with class II or III obesity ( BMI \> 35 kg/m2). In summary, there is an urgent need for more evidence on the specific role played by obesity in the development of COVID-19 complications, and more particularly of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Interventions

OTHERPatients admitted to Intensive Care Unit with SARS-CoV2

Patients admitted to Intensive Care Unit with SARS-CoV2

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant is aged 18 years or over * Has been admitted to ICU with COVID-19 disease. * COVID-19 disease has been confirmed by PCR for SARS-CoV-2 * Height and weight or BMI on admission has been recorded * Data has been collected in an ethical manner as part of a national database or clinical auditing process approved by the local institution or collaboration

Exclusion criteria

-There are no

Design outcomes

Primary

MeasureTime frameDescription
Relationship between body mass index (BMI) and SARS-CoV-23 monthsThe primary objective of this study is to investigate the relationship between obesity, as determined by body mass index (BMI), and severe pneumonia, as defined by the need of invasive mechanical ventilation ( IMV), among patient admitted in ICU for SARS-CoV-2, across multiple centers, in multiple countries.

Secondary

MeasureTime frameDescription
Associations between BMI and outcomes is independent of the known cardiometabolic risk factors3 monthsInvestigate whether the associations between BMI and outcomes is independent of the known cardiometabolic risk factors, hypertension, diabetes, dyslipidemia, and current smoking.
Investigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation3 monthsInvestigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation
Investigate the modifying effects of age and sex on the associations between BMI and outcome: mortality3 monthsInvestigate the modifying effects of age and sex on the associations between BMI and outcome: mortality

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026